I am a
Home I AM A Search Login

Papers of the Week

2020 Aug 29

Int J Neuropsychopharmacol

Esketamine Nasal Spray for Rapid Reduction of Depressive Symptoms in Patients with Major Depressive Disorder Who Have Active Suicide Ideation with Intent: Results of a Phase 3, Double-Blind, Randomized Study (ASPIRE II).


Patients with major depressive disorder (MDD) having active suicidal ideation with intent require immediate treatment.